Title : Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT.

Pub. Date : 2017 Aug 24

PMID : 28837141






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-beta1/STAT3 axis-regulated EMT. Metformin signal transducer and activator of transcription 3 Homo sapiens
2 Furthermore, based on the effect of metformin on the activation of STAT3 and expression of TGF-beta1, we propose that metformin exerts its effects by targeting the TGF-beta1/STAT3 axis. Metformin signal transducer and activator of transcription 3 Homo sapiens
3 Furthermore, based on the effect of metformin on the activation of STAT3 and expression of TGF-beta1, we propose that metformin exerts its effects by targeting the TGF-beta1/STAT3 axis. Metformin signal transducer and activator of transcription 3 Homo sapiens
4 Furthermore, based on the effect of metformin on the activation of STAT3 and expression of TGF-beta1, we propose that metformin exerts its effects by targeting the TGF-beta1/STAT3 axis. Metformin signal transducer and activator of transcription 3 Homo sapiens
5 Furthermore, based on the effect of metformin on the activation of STAT3 and expression of TGF-beta1, we propose that metformin exerts its effects by targeting the TGF-beta1/STAT3 axis. Metformin signal transducer and activator of transcription 3 Homo sapiens